Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Verifica-M 1000mg/50mg Tablet

Prescription Icon
Prescription Required

Marketer

Lupin Ltd

Salt Composition

Metformin (1000mg) + Vildagliptin (50mg)

Overview Verifica-M 1000mg/50mg Tablet

Diabeticare Duo 1000mg/50mg tablets combine two medications to manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps mitigate serious diabetic complications like renal impairment and vision loss, potentially lowering the risk of cardiovascular events. Diabeticare Duo may be administered independently or in conjunction with other antidiabetic therapies. Optimal efficacy necessitates adherence to a balanced diet and regular physical activity. Dosage is personalized, considering individual health status, glucose levels, and existing medications. Consuming the tablets with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes benefits; discontinuation should only occur under physician guidance. Effective blood sugar control minimizes future complications. Continued adherence to the prescribed diet and exercise regimen is crucial for overall diabetes management, as lifestyle significantly impacts blood sugar regulation. Commonly reported side effects include diarrhea, nausea, vomiting, indigestion, headache, pharyngitis, asthenia, GERD, hyperhidrosis, and anorexia. Hypoglycemia is a potential adverse effect, particularly when combined with insulin or sulfonylureas; appropriate recognition and management strategies are essential. This medication isn't universally suitable. Prior to commencement, inform your physician of any history of renal, hepatic, or cardiac disease, pancreatic disorders, or significant alcohol consumption. Pregnant or lactating women should seek medical advice before use. Interaction with other medications is possible; complete disclosure of all medications is crucial for safety. Alcohol consumption should be minimized due to its potential to reduce blood glucose. Your doctor will monitor renal function and blood glucose levels throughout the treatment period.

Uses of Verifica-M 1000mg/50mg Tablet

Managing type 2 diabetes

Major Benefits of Verifica-M 1000mg/50mg Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the Verifica-M 1000mg/50mg tablet whole; avoid chewing, crushing, or fracturing it. Consume it with a meal.

Common Side effects of Verifica-M 1000mg/50mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Verifica-M 1000mg/50mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the Verifica-M 1000mg/50mg tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.

How Verifica-M 1000mg/50mg Tablet works:

Combivir-1000 contains a dual-action formulation of two anti-diabetic medications.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Verifica-M 1000mg/50mg Tablet with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Verifica-M 1000mg/50mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing this medication. Seek medical advice before use.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Breastfeeding while taking Verifica-M 1000mg/50mg tablets is likely inadvisable. Preliminary human evidence indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Verifica-M 1000mg/50mg tablets. Dosage modification may be necessary; physician consultation is advised.

LiverLiverUNSAFE

Patients with liver conditions should likely avoid Verifica-M 1000mg/50mg tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Verifica-M 1000mg/50mg Tablet :

Should you forget a Verifica-M 1000mg/50mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Verifica-M 1000mg/50mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Verifica-M 1000mg/50mg Tablet

Verifica-M 1000mg/50mg tablets rarely cause hypoglycemia by themselves. However, low blood sugar can result from inadequate caloric intake while using this medication. Symptoms such as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, and shakiness may indicate hypoglycemia. These symptoms are more pronounced if meals are missed or delayed, alcohol is consumed, excessive exercise occurs, or other antidiabetic medications are taken concurrently. Therefore, regular blood sugar monitoring is crucial. Always carry a quick-acting sugar source, such as glucose tablets, honey, or fruit juice.
Nausea and vomiting are possible side effects of Verifica-M 1000mg/50mg Tablet. If vomiting occurs, sip small amounts of water or other fluids frequently. Consult your doctor if vomiting continues or you experience dehydration symptoms such as dark, strong-smelling urine and infrequent urination. Do not take other medications without your doctor's advice.
Verifica-M 1000mg/50mg Tablets are contraindicated in patients allergic to any ingredient. This medication should also not be used by individuals with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Verifica-M 1000mg/50mg tablets combine the anti-diabetic medications metformin (a biguanide) and vildagliptin. Metformin reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is contraindicated for individuals under 18.
Lactic acidosis, a serious medical emergency (also known as MALA, or Metformin-associated lactic acidosis), is a possible, though rare, side effect of Verifica-M 1000mg/50mg Tablet. This condition results from excessive lactic acid in the bloodstream and is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms can include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience any of these, discontinue Verifica-M 1000mg/50mg Tablet immediately and seek medical attention.
Prolonged use of Verifica-M 1000mg/50mg Tablets can lead to Vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia and neurological complications.
Verifica-M 1000mg/50mg tablets are safe when used as directed by your doctor. However, even with proper dosage, side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, and low blood sugar (especially if using insulin or sulphonylurea) may occur. Report any persistent issues to your physician.
Verifica-M 1000mg/50mg Ta...
124
MRP 151
17% off